Literature DB >> 10049240

Caz-hi, and extended-spectrum TEM beta-lactamase (TEM-61), is derived from Caz-lo (TEM-11) by in vivo selection.

T De Baere, M Vaneechoutte, G Verschraegen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10049240      PMCID: PMC106049     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  10 in total

1.  beta-Lactamases: quality and resistance.

Authors:  Antone A. Medeiros
Journal:  Clin Microbiol Infect       Date:  1997-02       Impact factor: 8.067

2.  Development of "oligotyping" for characterization and molecular epidemiology of TEM beta-lactamases in members of the family Enterobacteriaceae.

Authors:  C Mabilat; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

3.  A standard numbering scheme for the class A beta-lactamases.

Authors:  R P Ambler; A F Coulson; J M Frère; J M Ghuysen; B Joris; M Forsman; R C Levesque; G Tiraby; S G Waley
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

Review 4.  More extended-spectrum beta-lactamases.

Authors:  G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

5.  Nomenclature of TEM beta-lactamases.

Authors:  K Bush; G Jacoby
Journal:  J Antimicrob Chemother       Date:  1997-01       Impact factor: 5.790

Review 6.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

7.  Molecular characterisation by PCR-restriction fragment length polymorphism of TEM beta-lactamases.

Authors:  G Arlet; G Brami; D Décrè; A Flippo; O Gaillot; P H Lagrange; A Philippon
Journal:  FEMS Microbiol Lett       Date:  1995-12-15       Impact factor: 2.742

8.  Ceftazidime-resistant Enterobacteriaceae isolates from three Polish hospitals: identification of three novel TEM- and SHV-5-type extended-spectrum beta-lactamases.

Authors:  M Gniadkowski; I Schneider; R Jungwirth; W Hryniewicz; A Bauernfeind
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

9.  Plasmid-mediated beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli resistant to ceftazidime.

Authors:  A Vuye; G Verschraegen; G Claeys
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

10.  Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens.

Authors:  H Knothe; P Shah; V Krcmery; M Antal; S Mitsuhashi
Journal:  Infection       Date:  1983 Nov-Dec       Impact factor: 3.553

  10 in total
  2 in total

1.  Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals.

Authors:  Michael R Mulvey; Elizabeth Bryce; David Boyd; Marianna Ofner-Agostini; Sara Christianson; Andrew E Simor; Shirley Paton
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

2.  Extended-Spectrum beta-lactamase (ESBL) producing Enterobacter aerogenes phenotypically misidentified as Klebsiella pneumoniae or K. terrigena.

Authors:  Geert Claeys; Thierry De Baere; Georges Wauters; Patricia Vandecandelaere; Gerda Verschraegen; An Muylaert; Mario Vaneechoutte
Journal:  BMC Microbiol       Date:  2004-12-24       Impact factor: 3.605

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.